Prise en charge du patient adulte se plaignant d'insomnie en médecine générale. Médecine Sommeil, vol.4, pp.5-27, 2007. ,
Agency for Healthcare Research and Quality (US), 2005. ,
Ancien Président de l'Association mondiale de psychiatrie Membre de l'Académie de médecine, p.1082 ,
Manifestations and Management of Chronic Insomnia in Adults. Agency for Healthcare Research and Quality (US), 2005. ,
Prévalence de l'insomnie : actualité épidémiologique. Médecine Sommeil, vol.7, pp.139-184, 2010. ,
Prevalence of insomnia in a survey of 12,778 adults in France, J Sleep Res, vol.9, issue.1, pp.35-42, 2000. ,
Societal costs of insomnia, Sleep Med Rev, vol.14, issue.6, pp.379-89, 2010. ,
La perception de l'insomnie en médecine générale: Enquête auprès de 6 043 médecins généralistes. Presse Médicale, vol.34, pp.1358-62, 2005. ,
Nonpharmacologic treatments of insomnia, J Clin Psychiatry, vol.53, pp.37-41, 1992. ,
Association between benzodiazepines and recurrent falls: a cross-sectional elderly population-based study, J Nutr Health Aging, vol.15, issue.1, pp.72-79, 2011. ,
Benzodiazepines, Z-drugs and the risk of hip fracture: A systematic review and meta-analysis, PloS One, vol.12, issue.4, p.174730, 2017. ,
Is benzodiazepine use a risk factor for cognitive decline and dementia? A literature review of epidemiological studies, Psychol Med, vol.35, issue.3, pp.307-322, 2005. ,
Benzodiazepine use and risk of incident dementia or cognitive decline: prospective population based study, BMJ, vol.352, p.90, 2016. ,
, GABA and Sleep: Molecular, Functional and Clinical Aspects, pp.3-23, 2010.
The efficacy and safety of drug treatments for chronic insomnia in adults: a meta-analysis of RCTs, J Gen Intern Med, vol.22, issue.9, pp.1335-50, 2007. ,
Association Between Zolpidem and Suicide: A Nationwide Population-Based Case-Control Study, Mayo Clin Proc, vol.91, issue.3, pp.308-323, 2016. ,
, Etat des lieux de la consommation des benzodiazépines -Point d'Information -ANSM : Agence nationale de sécurité du médicament et des produits de santé, 2018.
The French addictovigilance network clinical assessment: Z-drugs, true false twins, Expert Opin Drug Saf, vol.16, issue.9, pp.1063-1072, 2017. ,
Pharmacoepidemiological characterisation of zolpidem and zopiclone usage, Eur J Clin Pharmacol, vol.69, issue.11, pp.1965-72, 2013. ,
Mésusage des médicaments du sommeil et de la vigilance: De l'effet indésirable à l'addiction, Ann Pharm Fr, vol.65, issue.4, pp.265-272, 2007. ,
, Prescription obligatoire du zolpidem sur ordonnance sécurisée -Point d'Information -ANSM : Agence nationale de sécurité du médicament et des produits de santé, 2018.
Evaluation de l'impact de la réforme des conditions de prescription et délivrance du zolpidem: étude pilote, 2018. ,
Impact de la nouvelle réglementation du zolpidem -enquête dans la circonscription départementale du Rhône, Pharm Hosp Clin [Internet], 2018. ,
Nouvelles règles de prescription et de délivrance du flunitrazépam: étude de l'impact sur la consommation en hypnotiques d'une cohorte. France, 2004. ,
Impacts de la nouvelle réglementation du flunitrazépam sur la consommation d'hypnotiques. Thérapie, vol.58, pp.425-455, 2003. ,
An Insight into Z-Drug Abuse and Dependence: An Examination of Reports to the European Medicines Agency Database of Suspected Adverse Drug Reactions, Int J Neuropsychopharmacol, vol.22, issue.4, pp.270-277, 2019. ,
, Guidance | Guidance on the use of zaleplon, zolpidem and zopiclone for the short-term management of insomnia | Guidance | NICE, 2019.
, Newer hypnotic drugs for the short-term management of insomnia: a systematic review and economic evaluation, 2019.
Potential benefits of zolpidem in disorders of consciousness, Expert Rev Clin Pharmacol, vol.10, issue.9, pp.983-92, 2017. ,
Effectiveness of Valerian on insomnia: A meta-analysis of randomized placebo-controlled trials, Melatonin for the Treatment of Insomnia: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines -NCBI Bookshelf, vol.11, pp.505-516, 2010. ,
Valerian for insomnia: a systematic review of randomized clinical trials, Sleep Med, vol.1, issue.2, pp.91-100, 2000. ,
Pharmacocinétique chez le sujet âgé, 2008. ,
Antidepressants for insomnia in adults, Cochrane Database Syst Rev, vol.5, p.10753, 2018. ,
A Systematic Review and Meta-Synthesis of Patients' Experiences and Perceptions of Seeking and Using Benzodiazepines and Z-Drugs: Towards Safer Prescribing. The Patient, vol.10, pp.1-15, 2017. ,
High-dose benzodiazepine dependence: a qualitative study of patients' perception on cessation and withdrawal. BMC Psychiatry, vol.15, p.116, 2015. ,
Dependence, misuse, and beliefs regarding use of hypnotics by elderly psychiatric patients taking zolpidem, estazolam, or flunitrazepam. Asia-Pac Psychiatry Off J Pac Rim Coll Psychiatr, vol.7, pp.298-305, 2015. ,
Correlates of dependence and beliefs about the use of hypnotics among zolpidem and zopiclone users, Subst Use Misuse, vol.50, issue.3, pp.350-357, 2015. ,
Règles de bon usage des benzodiazépines, Presse Médicale, vol.47, issue.10, pp.872-879, 2018. ,
, Arrêt des benzodiazépines et médicaments apparentés : démarche du médecin traitant en ambulatoire
, , 2019.
,
, Conseil National de l'Ordre des Médecins, 2019.
, , 2019.
Evaluating patients' experiences with individual physicians: a randomized trial of mail, internet, and interactive voice response telephone administration of surveys, Med Care, vol.44, issue.2, pp.167-74, 2006. ,
, Faking it: social desirability response bias in self-report research, vol.25, p.10, 2005.